What is Lexicon Pharmaceuticals's investing cash flow?

Lexicon Pharmaceuticals (LXRX) reported investing cash flow of -$70.26M in Q1 2026.

How has Lexicon Pharmaceuticals's investing cash flow changed year-over-year?

Lexicon Pharmaceuticals's investing cash flow decreased by 273.1% year-over-year, from $40.58M to -$70.26M.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Lexicon Pharmaceuticals LXRX Investing Cash Flow

Investing Cash Flow at other companies

Eli LillyLLY

-$3.92B-16.8%

PfizerPFE

$785M-76.0%

Merck & Co.MRK

-$10.21B-587%

Vertex PharmaceuticalsVRTX

-$431.9M-674%

CytokineticsCYTK

$145.49M+37.3%

Zevra Therapeutics, Inc.ZVRA

$79.62M+655%

Other financials

Income statement

See full

Revenue$21.1M+1,572%

Gross profit$21.0M+1,604%

Operating income-$996.0K+96.1%

Net income-$1.0M+95.9%

EPS (diluted)$0.00+100%

Balance sheet

See full

Cash & equivalents$67.1M+6.7%

Total debt$57.7M-45.7%

Total equity$202.9M+64.9%

Total assets$268.8M-9.7%

Cash flow

See full

Operating cash flow-$14.7M+66.4%

CapEx--100%

Free cash flow-$17.2M+21.5%

Valuation

See full

Market cap$986.12M+262%

Enterprise value$976.73M+209%

P/S14.2×+5.4×

Profitability

See full

Gross margin99.5%+1.5pp

Operating margin-34.8%-16.8pp

Net margin-37.5%-18.1pp

FCF margin-578.5%-283pp

Returns & leverage

See full

Return on equity-16%-7.2pp

Debt / equity0.3×-0.6×

Current ratio18.8×+16.6×

Where this comes from

Reported directly by Lexicon Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lexicon Pharmaceuticals's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lexicon Pharmaceuticals's investing cash flow?: Lexicon Pharmaceuticals (LXRX) reported investing cash flow of -$70.26M in Q1 2026.
How has Lexicon Pharmaceuticals's investing cash flow changed year-over-year?: Lexicon Pharmaceuticals's investing cash flow decreased by 273.1% year-over-year, from $40.58M to -$70.26M.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.